Fig. 2.
Evolution of T2D status in 126 patients of the cohort study, throughout the follow-up, 1 and 10 years after RYGB. T2D remission was considered if HbA1c was below 6.5%, in the absence of any antidiabetic drug. Abbreviations: 1y-DR – Diabetes remission in the first year after RYGB; 1y-NDR – No diabetes remission in the first year after RYGB; 10y-DR – Diabetes remission group at 10 or more years after RYGB; 10y-Relapse – Relapse group at 10 or more years after RYGB; 10-NDR – Never diabetes remission group at 10 or more years after RYGB